GPT and Hepatic fibrosis: As expected, hepatic fibrosis and injury were exacerbated in the miR-665-3p agomir-treated HFD mice, as evidenced by the increased levels of hepatic hydroxyproline and serum ALT and AST (Figure 3(d-e)).